Site Search



Yvette Bordelon, M.D., Ph.D.

Email Address:
ybordelon@mednet.ucla.edu

Office Address:
A-149 RNRC
710 Westwood Plaza
Los Angeles, CA 90095
UNITED STATES

Work Phone Number:
(310) 794-1195
310-206-2154



Login to the Faculty Database

Department / Division Affiliations
Assistant Professor, Neurology
Member, Brain Research Institute, Center for Neurodegenerative Disease Studies

Bio:

Dr. Bordelon received her MD and PhD degrees from the University of Pennsylvania. Her thesis work was performed with Dr. Marie-Francoise Chesselet and involved investigating mechanisms of cell death in an animal model of Huntington disease. She went on to residency training at Massachusetts General and Brigham and Women???s Hospitals and then did a Movement Disorders Fellowship at Columbia University before joining the Neurology faculty at UCLA in 2004. Her clinical work involves the diagnosis and treatment of Movement Disorders and her clinical research interests include clinical trials and development of biomarkers of disease in this subspecialty.

Publications:

Add here . . . ; .
O'Duffy, A. E. Bordelon, Y. M. McLaughlin, B. Killer proteases and little strokes--how the things that do not kill you make you stronger. J Cereb Blood Flow Metab. 2007; 27(4): 655-68.
Bordelon, YM Chesselet, MF Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia. Neuroscience. 1999; 93(3): 843-53.
Bartzokis, G Lu, PH Tishler, TA Fong, SM Oluwadara, B Finn, JP Huang, D Bordelon, Y Mintz, J Perlman, S Myelin Breakdown and Iron Changes in Huntington's Disease: Pathogenesis and Treatment Implications. Neurochem Res. 2007; .
Frucht, SJ Houghton, WC Bordelon, Y Greene, PE Louis, ED A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology. 2005; 65(12): 1967-9.
Frucht, SJ Bordelon, Y Houghton, WH Reardan, D A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Movement disorders : official journal of the Movement Disorder Society. 2005; 20(10): 1330-7.
Frucht, SJ Bordelon, Y Houghton, WH Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem). Movement disorders : official journal of the Movement Disorder Society. 2005; 20(6): 745-51.
Bordelon, YM Mackenzie, L Chesselet, MF Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum. The Journal of comparative neurology. 1999; 412(1): 38-50.
Bordelon, YM Chesselet, MF Ereci????ska, M Silver, IA Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience. 1998; 83(2): 459-69.
Bordelon, YM Chesselet, MF Nelson, D Welsh, F Erecinska, M Energetic dysfunction in quinolinic acid-lesioned rat striatum. Journal of neurochemistry. 1997; 69(4): 1629-39.
Gurevich, EV Bordelon, Y Shapiro, RM Arnold, SE Gur, RE Joyce, JN Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Archives of general psychiatry. 1997; 54(3): 225-32.